Clinical Trial Update: Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating corifollitropin alfa for repeated controlled ovarian stimulation in IVF completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Elonva (corifollitropin alfa)

Snippet

Sponsor: Organon and Co | Conditions: In Vitro Fertilization | Phase 3 | Status: COMPLETED | Results posted: 2015-04-23